Dudediligence.

Dyadic International, Inc

DYAINASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

36.4M

on 2026-06-30, from 29.2M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

S-3 of 2024-04-24. Not read yet. S-3 ↗

$4.2M

Craig-Hallum Capital Group, agreement of 2026-03-06. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

The 10-Q filed 2026-08-12 is not read yet.

Cash

1.7 quarters

$3.1M on 2026-06-30 ÷ $1.9M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2026-08-13Registered direct offering3,625,000$0.795$2.9M424B5 ↗
2025-07-30Public offering6,052,000$0.95$5.7M424B5 ↗